Clinical Trial Update: SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SYL040012 assessing tolerance and effects on intraocular pressure in people with glaucoma or ocular hypertension (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• SYL040012

Snippet

Sponsor: Sylentis, S.A. | Conditions: Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED